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Abstract
Chronic human immunodeficiency virus-1 (HIV-1) infection in patients leads to multi-
lineage hematopoietic abnormalities or pancytopenia. The deficiency in hematopoietic pro-
genitor cells (HPCs) induced by HIV-1 infection has been proposed, but the relevant mecha-
nisms are poorly understood. We report here that both human CD34+CD38- early and
CD34+CD38+ intermediate HPCs were maintained in the bone marrow (BM) of humanized
mice. Chronic HIV-1 infection preferentially depleted CD34+CD38- early HPCs in the BM
and reduced their proliferation potential in vivo in both HIV-1-infected patients and human-
ized mice, while CD34+CD38+ intermediate HSCs were relatively unaffected. Strikingly,
depletion of plasmacytoid dendritic cells (pDCs) prevented human CD34+CD38- early HPCs
from HIV-1 infection-induced depletion and functional impairment and restored the gene
expression profile of purified CD34+ HPCs in humanized mice. These findings suggest that
pDCs contribute to the early hematopoietic suppression induced by chronic HIV-1 infection
and provide a novel therapeutic target for the hematopoiesis suppression in HIV-1 patients.
Author summary
Multi-lineage hematopoietic abnormalities generally occur during chronic infection
which results in a disorder of human leukocyte development and differentiation, contrib-
uting to human immunodeficiency virus-1 (HIV-1)-infection induced immune-patho-
genesis in AIDS patients. Although successful antiretroviral therapy can reduce plasma
viral loads to undetectable levels and ameliorate HIV-1-associated hemato-suppression,
immune cell development is only partially restored. The mechanism for the abnormal
hematopoiesis occurring during chronic HIV-1 infection remains unclear. HIV-1 infec-
tion may directly or indirectly functionally impair hematopoietic progenitors by either
viral products or induction of persistent inflammatory responses, leading to hematopoiesis
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obstacles. Here, we show that HIV-1 infection significantly depleted and functionally
impaired human hematopoietic progenitors in the bone marrow of both HIV-1-infected
patients and humanized mice through a plasmacytoid dendritic cell (pDC)-dependent
mechanism, as depletion of pDCs significantly recovered cell numbers and functions and
gene expression profiles of hematopoietic progenitor cells in humanized mice in vivo. Our
study clarifies a novel mechanism underlying hemato-suppression induced by chronic
HIV-1 infection and provides a novel strategy to halt HIV-1 disease.
Introduction
Human immunodeficiency virus-1 (HIV-1) infection in patients leads to multi-lineage hema-
topoietic abnormalities, including anemia, granulocytopenia and thrombocytopenia [1,2].
Abnormalities in fetal hematopoiesis have also been reported in aborted fetuses from HIV-1
seropositive women [3]. The defect in hematopoietic progenitor cells (HPCs) or hematopoiesis
induced by HIV-1 has been proposed [1,4,5]. In addition, the degree of the hematopoietic
pathology correlates with the stage of disease progression [6], and end-stage disease is charac-
terized by pancytopenia [1]. Long-term bone marrow (BM) cultures from HIV-1-infected
patients exhibit low CD34+ progenitor cell growth and differentiation [7,8], indicating func-
tional impairment of early hematopoietic progenitors. Although the successful highly active
antiretroviral therapy (HAART) clearly ameliorates HIV-1-associated hemato-suppression, it
does not completely restore blood cell development [9]. These observations indicate that
hematopoietic failure is an important aspect of HIV-1 infection-induced pathogenesis [10].
HPCs are comprised of diverse populations, including both early and intermediate progeni-
tors. Each subpopulation expresses distinct sets of cell surface antigens, although they all
express the cell surface antigen CD34 [11,12]. Early and intermediate populations can be dis-
tinguished by the expression of CD38, with the former being negative for CD38 and the latter
being positive for this antigen. Functionally, intermediate progenitors include common mye-
loid progenitors that can give rise to all myeloid, erythroid and megakaryocyte lineages. Due
to limited access to the BM in humans, properties of human HPC subsets and their alterations
in healthy and HIV-1 disease states have been difficult to characterize.
The mechanisms underlying abnormal hematopoiesis in HIV-1 infection remains unclear
due to the paucity of robust animal models that mimic human hemato-suppression in vivo.
Although previous studies failed to detect HIV-1 infection of HPCs, recent reports indicated
that HIV-1 could directly infect HPC subsets and lead to their impairment [13–16]. In addi-
tion, HIV-1 proteins such as Nef [17] and prolonged treatment with antiretroviral drugs could
also compromise hematopoietic progenitors [18]. Although these studies investigated a litany
of direct and indirect causes of HIV-1-associated hemato-suppression, how HIV-1 affects
hematopoiesis in vivo remains unclear.
There is emerging evidence that certain cytokines induced during inflammation have sig-
nificant effects on HPCs in the BM. Type I and II interferon (IFN) [19–23], tumor necrosis fac-
tor (TNF) [24–26] and lipopolysaccharide (LPS) [27,28] directly stimulate HPC proliferation
and differentiation, thereby increasing the short-term output of mature effector leukocytes.
However, chronic inflammatory cytokine signaling can lead to functional exhaustion of HPCs
[19,22,28]. Our previous study demonstrated that plasmacytoid dendritic cells (pDCs), the
major type I interferon (IFN-I)-producing cells during acute or chronic HIV-1 infection,
could inhibit viral replication while significantly contributing to HIV-1 infection-induced
immune-pathogenesis, including increased immune cell death and reduced immune
pDC-dependent HPC depletion in HIV-1 infection
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reconstitution of human CD45+ cells in humanized mice in vivo [29]. These findings suggest
that pDCs play a pivotal role in the hemato-suppression induced by chronic HIV-1 infection.
In this study, we sought to understand the role of pDCs in HIV-1-associated hemato-sup-
pression in a humanized mouse model in vivo. We discovered that HIV-1 infection depleted
CD34+CD38- early HPCs and functionally impaired human CD34+ HPCs in the BM of
patients and humanized mice with HIV-1 infection. This phenomenon was further found to
be dependent on pDCs, as depletion of pDCs significantly recovered HPC cell numbers and
multi-lineage colony-forming functions. Our present study therefore reveals a novel mecha-
nism for hematopoiesis suppression induced by chronic HIV-1 infection and provides a new
strategy to rescue HPC function and halt HIV-1 disease progression.
Results
Development and maintenance of functional human HPCs in humanized
mice
By gating on live human CD45+ cells (VLD-mCD45-) with a lymphoid morphology that lacked
common markers (Lineage−) for T cells (CD3), B cells (CD19 and CD20) or NK cells (CD56
and CD16), we identified human BM-derived HPCs as CD34+ cells, which included early
CD34+CD38- and intermediate CD34+CD38+ subpopulations (S1 Fig). We then analyzed the
human HPCs from the BM of humanized mice at various time points after human CD34+ cell
transplantation. The early and intermediate HPCs could be detected significantly at both 16
weeks and 50 weeks after CD34+ cell transplantation with relatively stable levels (Fig 1A).
To determine if human HPCs derived from humanized mice were functional, human
CD34+ cells were isolated from the BM of humanized mice and human fetal livers, and col-
ony-forming unit (CFU) assays were performed by culturing CD34+ HPCs in a complete
methylcellulose medium system. Two weeks later, HPCs derived from the BM of humanized
mice produced 50 colonies on average for every 500 CD34+ cells plated, similar to that of
human fetal liver-derived CD34+ cells (Fig 1B). All hematopoietic lineages were generated in
cultures from the BM of humanized mice. In addition, HPCs from humanized mice could pro-
liferate and differentiate into various blood lineage cells in vitro at a similar frequency to that
of CD34+ cells from human fetal livers, including colony-forming unit-granulocyte and mac-
rophage (CFU-GM), colony-forming unit-erythroid (CFU-E) and colony-forming unit-granu-
locyte, erythroid, macrophage, megakaryocyte (CFU-GEMM) (Fig 1B). We then measured the
proliferation capacity of HPCs by BrdU labeling in vivo and found that 8.9% of human CD34+
cells showed proliferation (Fig 1C). Notably, the CD34+CD38- early HPCs were much more
proliferative, with an average of nearly 25% of cells being BrdU positive, which was signifi-
cantly higher than the relatively quiescent CD34+CD38+ intermediate HPCs with 1.6% BrdU
labeling (Fig 1C and 1D). These data suggest that the human CD34+CD38- early HPCs and
CD34+CD38+ intermediate HPCs were both functionally developed and maintained in the
BM of humanized mice.
CD34+CD38- early HPCs are preferentially depleted in vivo in both HIV-1
chronically infected patients and humanized mice
Utilizing the robust animal model, we were able to investigate whether chronic HIV-1 infec-
tion affected human HPCs. HIV-1 infection was established in humanized mice, as measured
by plasma HIV-1 RNA (copies/mL, S2 Fig). On termination, we also measured HIV-1 gag p24
expression in both T cells and CD34+ HPCs by flow cytometry. Although a previous study sug-
gested that HIV-1 has the potential to infect intermediate CD34+CD38+ HPCs [13], we found
pDC-dependent HPC depletion in HIV-1 infection
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that p24 expression was absent in BM CD34+ HPCs from humanized mice with HIV-1 infec-
tion; in contrast, CD3+ T cells showed high levels of p24 expression (10.5%) (Fig 2A). Further
analysis indicated that the frequency of CD34+CD38- early HPCs was largely decreased in
humanized mice with chronic HIV-1 infection, while the proportion of intermediate
CD34+CD38+ HSCs was relatively expanded (Fig 2B).
Summarized data further demonstrated that chronic HIV-1 infection significantly reduced
CD34+CD38- early HPCs by nearly 8-fold as compared to the non-infected animals; mean-
while, the proportion of CD34+CD38+ intermediate HPCs was increased from 76% to nearly
100% as shown in the stacked bar graph (Fig 2C). When the absolute cell counts of early
and intermediate HPCs were calculated, the number of CD34+CD38- early HPCs was dramati-
cally reduced in the BM of chronically infected animals (Fig 2D), while CD34+CD38+ interme-
diate HPC counts were affected mildly (Fig 2E). These results suggest a depletion of early
HPCs during chronic HIV-1 infection. Importantly, we observed a similar depletion of BM
CD34+CD38- early HPCs in HIV-1-infected patients. As shown in Fig 2F, the percentage of
CD34+CD38- early HPCs was significantly decreased within total CD34+ HPCs in an HIV-
Fig 1. Development of functional human CD34+ HPCs in BM of humanized mice. (A) Representative dot plots showing distribution of human
early CD34+CD38- and intermediate CD34+CD38+ HPCs in BM of humanized mice. Numbers indicate percentages of CD34+CD38- and
CD34+CD38+ HPCs (gated on hCD45+mCD45-VLD-Lin-CD34+ cells). Data are representative of two independent experiments with mice
reconstituted with three human donors. (B) Pooled data indicating numbers of colonies that developed from human CD34+ HPCs from BM of
humanized mice and human fetal livers (n = 6). Total colonies, CFU-GM, colony-forming unit-granulocyte, macrophage; CFU-E, colony-forming unit-
erythroid; CFU-GEMM, colony-forming unit-granulocyte, erythroid, macrophage, megakaryocyte. (C) Representative histograms showing
proliferation of CD34+ HPCs in vivo through BrdU labeling in humanized mice. PBS mouse samples were used as controls (upper panels). Numbers
indicate percentages of BrdU+ HPCs within CD34+ HPC subsets. (D) Pooled data indicate percentages of BrdU+ CD34+ HPC subsets in BM of
humanized mice (n = 5). (B, D) Data are shown as the mean ± s.e.m.
https://doi.org/10.1371/journal.ppat.1006505.g001
pDC-dependent HPC depletion in HIV-1 infection
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Fig 2. Chronic HIV-1 infection preferentially depletes early CD34+CD38- HPCs in humanized mice in vivo. (A) Representative histograms
showing p24 expression on CD3+ T cells and CD34+ HPCs from BM of humanized mice with chronic HIV-1 infection. Numbers indicate
percentages of p24-expressing CD3+ T cells and CD34+ HPCs. Data are representative of three independent experiments with mice
reconstituted with two to three donors. (B) Representative dot plots showing chronic HIV-1 infection depleting early CD34+CD38- HPCs from BM
of humanized mice. Numbers indicate percentages of early CD38-CD34+ and intermediate CD34+CD38+ HPCs. (C) Pooled data indicating
mean percentages of early CD34+CD38- HPCs and intermediate CD34+CD38+ HPCs in BM of humanized mice with mock and HIV-1 infection
shown in the stacked bar graph. P values are shown. (D-E) Pooled data indicating absolute cell numbers of early CD34+CD38- HPCs (D) and
intermediate CD34+CD38+ HPCs (E) in BM of humanized mice with mock (n = 7) or chronic HIV-1 infection (n = 5). (F) Representative dot plots
showing chronic HIV-1 infection depleting early CD34+CD38- HPCs from BM of HIV-1-infected patients compared to that of healthy control (HC)
donors. Numbers indicate percentages of early CD38-CD34+ and intermediate CD34+CD38+ HPCs. (G-H) Pooled data indicating percentages
of early CD34+CD38- HPCs (G) and intermediate CD34+CD38+ HPCs (H) in BM of HC donors (n = 6) and HIV-1-infected patients (n = 5). (D, E,
G, H) Data are shown as the mean ± s.e.m. *P < 0.05 and ***P < 0.001 (two-tailed unpaired Student’s t-test).
https://doi.org/10.1371/journal.ppat.1006505.g002
pDC-dependent HPC depletion in HIV-1 infection
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1-infected patient when compared to a healthy control (HC). The depletion of CD34+CD38-
early HPCs in human BM from HIV-1 infection was strengthened by the addition of more
patients (n = 5) (Fig 2G). In contrast, the proportion of intermediate CD34+CD38+ HSCs was
increased within total HPCs in HIV-1-infected patients relative to those of HC subjects (Fig
2H). These data indicated that early CD34+CD38- HSCs were preferentially depleted by
chronic HIV-1 infection, and the humanized mouse is a highly relevant animal model that
mimics HIV-1-induced hemato-suppression conditions in patients.
Chronic HIV-1 infection inhibits proliferation of human HPCs in vivo
We next analyzed the effect of chronic HIV-1 infection on the homeostatic proliferation of
human HPCs in humanized mice. The results indicate that proliferation of human CD34+
cells in the BM was inhibited by approximately 3-fold in chronic HIV-1 infection compared to
the mock animals (Fig 3A). Consistent with the preferential reduction of CD34+CD38- HPCs,
BrdU-positive CD34+CD38- early HPCs were significantly decreased by chronic HIV-1 in-
fection; meanwhile, the proliferation of CD34+CD38+ intermediate HPCs was only mildly
reduced by chronic HIV-1 infection (Fig 3B and 3C). In terms of cell numbers, the early HPC
counts were significantly decreased by chronic HIV-1 infection compared with mock treat-
ment in mice (Fig 3D), while intermediate HPC counts were only slightly reduced (Fig 3E).
Thus, while both cell types were less proliferative in the presence of HIV-1, the more marked
difference was observed in CD34+CD38- cells. Therefore, chronic HIV-1 infection appeared to
suppress human hematopoiesis by inhibiting homeostatic proliferation of human early HPCs
in the BM.
Human CD34+ HPCs isolated from BM of mice chronically infected with
HIV-1 display impaired differentiation
In order to assess the quality of in vivo human HPCs during chronic HIV-1 infection, we mea-
sured CFU activity of purified human Lin-CD34+ HPCs from mock- or HIV-1-infected
humanized mice, including GM, E and GEMM (S3 Fig). As shown in Fig 4, HPCs isolated
from uninfected mice consistently produced over 50 colonies per 500 CD34+ cells on average,
whereas HPCs derived from HIV-1-infected mice produced less than 30 colonies per 500
CD34+ HPCs. Moreover, the ability of HPCs to generate all lineages, including GM, E and
GEMM, was also suppressed to some extent in chronically infected mice. Therefore, the results
indicated that chronic HIV-1 infection leads to the impaired differentiation of HPCs in vivo.
Decreased quantity and quality of CD34+CD38- early HPCs is
dependent on pDCs during chronic HIV-1 infection
Increasing reports have demonstrated that chronic inflammation could lead to the functional
exhaustion of BM HPCs [19,22,28]. Our recent study indicated that depletion of pDCs effi-
ciently rescued human CD45 cell reconstitution in humanized mice with chronic HIV-1 infec-
tion [29]. Thus, we hypothesized that pDCs may be responsible for the depletion of
CD34+CD38- early HPCs and their functional impairment during chronic HIV-1 infection.
To address the role of pDCs in the impairment of CD34+CD38- HPCs in HIV-1 infection,
humanized mice with chronic HIV-1 infection were treated with a pDC-depleting antibody
(15B) as in our previous report [29]. Similarly, the plasma viral load was increased upon the
depletion of pDCs and maintained at a higher level until termination (S4A Fig). Notably, the
depletion of pDCs significantly changed the percentage of CD34+CD38- early HPCs in the BM
from humanized mice with chronic HIV-1 infection (Fig 5A). Pooled data further confirmed
pDC-dependent HPC depletion in HIV-1 infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006505 July 31, 2017 6 / 20
that both the percentages and cell counts of CD34+CD38- early HPCs were restored by deple-
tion of pDCs in HIV-1-infected mice (Fig 5B and 5C). In contrast, pDC depletion did not
influence the percentages of CD34+CD38- early HPCs (CD38 expression) and their prolifera-
tion in vivo indicated by BrdU expression in the BM in the absence of HIV-1 infection (S4B
Fig). In addition, the cell counts of CD34+CD38+ intermediate HPCs showed only minor
recovery by the depletion of pDCs during chronic HIV-1 infection, which is consistent with
the slight decrease in proportion of CD34+CD38+ intermediate HPCs (Fig 5B and 5C).
Notably, only half of the animals showed a recovery in the proportion of CD34+CD38- early
HPCs after pDC depletion in Fig 5B, which prompted us to investigate whether the extent of
pDC depletion affected the effectiveness of rescue of CD34+CD38- early HPCs in humanized
mice with chronic HIV-1 infection. We therefore divided the 13 animals into two groups;
Fig 3. Chronic HIV-1 infection impairs proliferation of early CD34+CD38- HPCs in vivo of humanized mice. (A) Representative histograms
showing BrdU labeling of CD34+ HPC subsets from BM of humanized mice. Numbers indicate percentages of BrdU+ within the total CD34+
HPCs, early CD34+CD38- HPCs and intermediate CD34+CD38+ HPCs. (B-E) Pooled data indicating percentages of BrdU+ cells within early
CD34+CD38- HPCs (B) and intermediate CD34+CD38+ HPCs (C); and absolute cell numbers of BrdU+ early CD34+CD38- HPCs (D) and
intermediate CD34+CD38+ HPCs (E) in BM of mock (n = 4) and HIV-1-infected (n = 6) humanized mice. Data are shown as the mean ± s.e.m.
*P < 0.05 (two-tailed unpaired Student’s t-test).
https://doi.org/10.1371/journal.ppat.1006505.g003
pDC-dependent HPC depletion in HIV-1 infection
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animals with less than the median percentage of CD34+CD38- HPCs were placed in the
"non-rescued" group (n = 6), while the others were included in the "rescued" group (n = 7).
The rescued group was found to have significantly more CD34+CD38- early HPCs and fewer
CD34+CD38+ intermediate HPCs than the non-rescued group (S4C and S4D Fig). Impor-
tantly, the rescued mice showed a marked lack of pDCs in the BM and lower levels of IFN-α in
plasma compared with non-rescued mice (S4E and S4F Fig). Accordingly, the rescued mice
were also characterized by a higher level of HIV-1 replication than that of non-rescued mice
(S4G Fig). Thus, we observed that the CD34+CD38- early HPCs was negatively correlated with
pDC percentages within CD45+ cells in BM of these HIV-1 infected humanized mice with
pDC depletion (S4H Fig). These data indicated that the extent of rescue of CD34+CD38- early
HPCs was closely linked to in vivo pDC depletion rather than other potential causes such as
HIV viral load in humanized mice with chronic HIV-1 infection.
To further qualify HPCs after pDC depletion, Lin-CD34+ cells were purified for colony-
forming assays ex vivo. Cell colonies including GM, E and GEMM were found in culture (S3
Fig). The results demonstrated that pDC depletion could dramatically enhance CFU activity of
the Lin-CD34+ cell population as well as increase the quantity of each colony type individually
as compared with HIV-1-infected mice (Fig 5D).
Depletion of pDCs restores gene expression profile of human CD34+
HPCs
To understand how pDCs contribute to the impairment of HPCs during chronic HIV-1 infec-
tion, we analyzed gene expression of human HPCs in BM from HIV-1 chronically infected
Fig 4. Chronic HIV-1 infection impairs colony-forming activity of CD34+ HPCs in BM of humanized mice.
Pooled data indicate the number of colonies that developed from human CD34+ HPCs of mock (n = 4) and HIV-
1-infected (n = 5) mice. Data are shown as the mean and s.e.m. *P < 0.05 (two-tailed unpaired Student’s t-test).
https://doi.org/10.1371/journal.ppat.1006505.g004
pDC-dependent HPC depletion in HIV-1 infection
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humanized mice. Human Lin-CD34+ cells from BM of humanized mice were isolated and sub-
mitted for gene expression analysis by cDNA array (Fig 6A), as described in a previous study
[29]. A total of 3114 genes were significantly up-regulated, and 2994 genes were down-regu-
lated spontaneously in CD34+ HPCs from HIV-1-infected humanized mice as compared to
mock-treated mice (fold change> 2, Fig 6B and S5 Fig). Astonishingly, pDCs depletion during
chronic HIV-1 infection in mice restored most of the interferon-stimulating genes (ISGs) to
levels found in non-infected animals (S6A and S6B Fig). Along with the recovery of ISG gene
expression, only 924 genes were significantly up-regulated, and 364 genes were down-regu-
lated in BM CD34+ HPCs with pDCs depletion as compared to mock-treated mice (fold
change> 2, Fig 6B and S5 Fig). Thus, pDCs depletion resulted in a restoration of a total of
5664 genes among 6108 genes (> 92.7%) that changed during HIV-1 infection in humanized
mice, drawing back the whole gene expression profile to a pattern quite similar to that in
mock-infected mice (Fig 6B and S5 Fig).
We then searched the GeneGo database to identify potentially relevant pathways in the
genes influenced by chronic HIV-1 infection. The hematopoietic cell lineage was the most
affected pathway induced by chronic HIV-1 infection among the top 15 pathways, whereas
Fig 5. Depletion of pDCs during chronic HIV-1 infection rescues early CD34+CD38- HPCs in humanized mice. (A) Representative dot plots showing
the recovery of early CD34+CD38- HPCs in BM of chronic HIV-1-infected humanized mice with pDC depletion. Numbers indicate percentages of early
CD34+CD38- HPCs and intermediate CD34+CD38+ HPCs in various groups of mice. (B and C) Summary data of percentages (B) and absolute cell
numbers (C) of early CD34+CD38- HPCs and intermediate CD34+CD38+ HPCs from BM in mock (n = 11), HIV-1-infected (n = 12) and HIV-1-infected
humanized mice with pDC depletion (n = 13). Each dot represents one mouse. *P < 0.05 and ***P < 0.001 (two-tailed unpaired Student’s t-test). (D)
Summary data of CFU that developed from CD34+ HPCs of mock-infected mice (n = 4), HIV-1-infected mice (n = 5) and HIV-1-infected mice with pDC
depletion (n = 4). *P < 0.05 (two-tailed unpaired Student’s t-test). Error bars, s.e.m
https://doi.org/10.1371/journal.ppat.1006505.g005
pDC-dependent HPC depletion in HIV-1 infection
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Fig 6. Depletion of pDCs reverses the dysregulated gene expression profile of human CD34+ HPCs affected by HIV-1 infection. Humanized
mice were infected with HIV-1 JR-CSF and treated with 15B or control IgG at 11 weeks post-infection and terminated at 21 weeks post-infection.
huCD45+Lin-CD34+ cells from BM of mock, HIV-1/IgG or HIV-1/15B treated mice were purified by flow cytometry (> 95% purity). Total mRNA were isolated
and used for the cDNA microarray assay. (A) Heat map showing the relative expression of 6108 significantly up- or down-regulated genes indicated by the
pDC-dependent HPC depletion in HIV-1 infection
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those dysregulated genes were also significantly restored to mock levels in pDC-depleted BM
CD34+ HPCs of humanized mice chronically infected with HIV-1 (Fig 6C). We comprehen-
sively analyzed the 88 genes in the hematopoietic cell lineage pathway (S7A Fig) and found
that HIV-1 infection induced a significant up-regulation of 27 genes and down-regulation of
28 genes in humanized mice relative to mock controls (S7B Fig). However, depletion of pDCs
during HIV-1 infection only induced a significant change in expression of one gene in relation
to mock controls (S7B Fig). Summarized data further indicated that although HIV-1 infection
led to a significant change of most of the genes with more than a 2-fold change, pDC depletion
could attenuate the up-regulation of genes and restored the down-regulated genes to normal
levels during chronic HIV-1 infection (Fig 6D and S7C Fig). In particular, some genes related
to the HPC quiescent state (DTX3L and CXCR4) [30], colony forming capacity (CD34, CD38,
FLT3 and TGFBR1-3) [31], self-renewal and expansion capacity (Notch1-2, Jagged1-2 and Hes-
1) [32,33], as well as several important cell death genes were significantly altered by chronic
HIV-1 infection, while pDCs depletion in HIV-1-infected humanized mice largely restored
the abnormal expression of these genes to a similar pattern as seen in mock-infected mice (Fig
6E and 6F, S1 Table).
Simultaneously, we also performed mRNA expression analysis using spleen-derived CD45+
cells (S8A Fig). A total of 4757 genes were significantly up-regulated or down-regulated in
splenic CD45+ cells from HIV-1-infected humanized mice as compared to mock-infected
mice (fold change > 2, S8B Fig). The depletion of pDCs resulted in a restoration of about
44.0% of genes (2092/4757) of splenic cells changed by HIV-1 infection in humanized mice to
a pattern quite similar to that in mock-infected mice (S8B Fig). The pathway analysis indicated
that systemic lupus erythematosus (SLE) was the most affected pathway induced by chronic
HIV-1 infection (S8C Fig), whereas the dysregulated genes expressed by splenic CD45+ cells
were not significantly restored to mock levels in pDC-depleted humanized mice chronically
infected with HIV-1 (S8D Fig). We also analyzed 127 genes in the SLE pathway changed by
HIV-1 infection (S8E Fig) and found that HIV-1 infection induced significant changes of 48
genes relative to mock controls. However, depletion of pDCs during HIV-1 infection also
induced significant changes in expression of 115 genes in relation to mock controls (S8E Fig),
indicating that pDCs depletion failed to restore the changes in gene expression by spleen
CD45+ cells to normal levels during chronic HIV-1 infection (S8F Fig).
These data strongly suggest that pDCs has relatively unique effects on the numerical reduc-
tion and functional impairment of BM CD34+ HPCs in HIV-1 chronically infected humanized
mice, contributing to the suppression of hematopoiesis characterized by dysregulation of gene
expression profiles.
We finally tested whether IFN-I directly up-regulates CD38 expression on HPCs in vitro.
As shown in S9A and S9B Fig, neither IFN-α nor IFN-β showed any significant effect on
CD38 expression on CD34+ cells in vitro. In addition, IFN-I culture did not affect CD34+ HPC
expansion (S9C Fig). These data indicate that IFN-I did not directly affect CD38 expression
and expansion of CD34+ HPC cells in vitro.
color bars in huCD45+Lin-CD34+ cells from HIV-1-infected over mock-infected samples (green, suppressed genes; red, induced genes. Fold change 2).
(B) Table showing numbers of genes significantly up-regulated and down-regulated in humanized mice with HIV-1 infection treated with control IgG or 15B
antibody for pDC depletion. (C) Pathway maps representing a set of signaling and metabolic maps. Sorting was performed for statistically significant maps.
Experimental data are represented as green (JR-CSF + IgG) and red (JR-CSF + 15B) histograms. The height of the histogram corresponds to the relative
expression of particular pathways. (D) Fold changes of 88 genes from hematopoietic cell lineage in HIV-1-infected mice treated with control IgG or 15B
antibody for pDC depletion in relation to mock controls. (E) Expression levels of genes associated with HPC proliferation, differentiation and cell death in
huCD45+Lin-CD34+ cells are indicated by the heat-map color bars (green, suppressed genes; red, induced genes. Fold change 2). (F) Summary data of
the expression of HPC-associated genes, including CD38, HES1, Notch-1 and AML-1 in huCD45+Lin-CD34+ cells from various groups of mice (n = 4 per
group). Data are shown as the mean ± s.e.m. *P < 0.05 (two-tailed unpaired Student’s t-test).
https://doi.org/10.1371/journal.ppat.1006505.g006
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Discussion
The present study demonstrates, for the first time, that human CD34+CD38- early HSCs are sub-
ject to preferential depletion and functional impairment in vivo in the BM of humanized mice
with chronic HIV-1 infection, in a pDC-dependent fashion. This study thus reveals a new target
for the development of novel drugs targeting pDC activity to treat hematopoietic disorders dur-
ing chronic HIV-1 infection and also demonstrates the utility of humanized mice to investigate
important questions on HIV-1-mediated hematological abnormalities in the BM in vivo.
Previous studies have attempted to delineate the mechanism by which HIV-1 infection
induces the impairment of HPCs, but it remains an intractable question due to the lack of a
suitable experimental animal model that closely mimics human hematopoiesis during an
ongoing HIV-1 infection in vivo. Here, we provide evidence that both early and intermediate
HPCs are functionally developed and maintained for long-term self-renewal in the BM of
humanized mice in vivo. This animal model has been demonstrated to be persistently infected
by various strains of HIV-1 and develop major immune pathogenesis induced by acute or
chronic HIV-1 infection as observed in HIV-1 patients [29,34–36]. Importantly, Nixon et al.
made initial advances toward adopting a humanized mouse model to investigate an HIV-1
infection-induced hematopoiesis disorder [13]. Our present study underscores the rationale
for utilizing a humanized mouse model to study the impact of HIV-1 infection on hematopoi-
esis in vivo. Taken together, these studies support the humanized mouse model as an experi-
mentally amenable in vivo system for investigating HIV-1-associated pathogenesis.
Accumulating evidence has demonstrated that patients with long-term HIV-1 infection
exhibit a deficiency in hematopoiesis [1,4,5], although the stage at which HPCs are impaired by
HIV-1 infection is unclear. Nixon et al. showed that HPCs were susceptible to HIV-1 infection
in vitro and in vivo in humanized mice and concluded that direct infection of intermediate
CD34+CD38+ HPCs by HIV-1 adversely affected their hematopoietic potential and correlated
with the observed pancytopenia in HIV-1 infected patients [13]. In this study, we found that
CD34+CD38- early HPCs were preferentially depleted during chronic HIV-1 infection, which
correlated with the depression of hematopoiesis development and dysregulated gene expression
in bulk Lin-CD34+ HPCs. However, our study failed to detect significant productive infection of
Lin-CD34+ HPCs in the BM in vivo even with pDC depletion, as the depletion of pDCs led to
dramatically increased viral replication. One possible explanation for this finding is that different
HIV-1 strains may exhibit discrepancies during infection of HPCs in vivo. Future studies should
examine the effect on HPC subsets by infection with other HIV-1 strains with different tropisms.
The mechanisms leading to abnormal hematopoiesis have not been clearly addressed in
HIV-1 infection. Aside from the direct infection of HPC subsets, pDCs are possibly critical fac-
tors leading to hematopoietic suppression during HIV-1 infection, as the depletion of pDCs
rescued early HPCs and their hematopoiesis. Available lines of evidence have also demon-
strated that pDCs substantially mediate detrimental effects during chronic HIV-1 infection in
vivo, even while they inhibit viral replication [29,37–39]. In addition, pDCs can secrete other
pro-inflammatory cytokines, including TNF-α and IL-6. These chronic inflammatory cyto-
kines can lead to exhaustion of hematopoiesis [19,22,28]. Most importantly, pDCs are the
major IFN-I-producing cells during HIV-1 infection [29,40,41]. Currently, IFN-I is perhaps
the primary contributor, since depletion of pDCs completely abolished IFN-I responses in
humanized mice with chronic HIV-1 infection [29]. IFN-I has been recently demonstrated to
be actively involved in immune pathogenesis of chronic virus infection [39,42–45]. Our data
indicate that IFN-I did not directly affect CD38 expression on HPCs in vitro during short-
term culture although it possibly promote the maturation of embryonic hematopoietic stem
cells [46]. Other factors associated with chronic HIV-1 infection may contribute to IFN-
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induced HPC depletion and will be investigated in future study. Of course, we could not
exclude the possibility that HIV-1 products are involved in the dysregulation of hematopoietic
development. For example, HIV-1 Nef has been found to be responsible for hematopoietic
defects of the BM in HIV-1 infection, dependent on the presence and activation of the PPARγ
signaling pathway [17]. Thus, pDCs may contribute to abnormal hematopoiesis during chro-
nic HIV-1 infection directly through viral infection or indirectly via diverse cytokines. Taking
these studies into consideration, we also propose that HIV-1 infection may affect HPC func-
tion through multiple mechanisms (S10 Fig). Future studies should investigate in detail the
individual factors responsible for compromising hematopoietic activity.
In summary, pDCs play a pivotal role in the immune-pathogenesis and hematopoiesis
depression induced by chronic HIV-1 infection. This study, therefore, provides new insight
into HIV-1-induced dysregulation of hematopoiesis and provides a novel strategy for treating
abnormal hematopoiesis during chronic HIV-1 infection.
Materials and methods
Ethics statement
Approval for animal work was obtained from the University of North Carolina Institutional
Animal Care and Use Committee (IACUC ID: 14–100). The study protocol on human samples
was approved by the Institutional Review Board and the Ethics Committee of Beijing 302 Hos-
pital in China. The written informed consent was obtained from each subject. Human BM
samples were obtained from adult donors with liver transplantation as healthy controls and
from HIV-1-infected adult patients for pathological diagnosis. Human fetal livers and thy-
muses (gestational age 16 to 20 weeks) were obtained from medically indicated or elective ter-
mination of pregnancies through a non-profit intermediary working with outpatient clinics
(Advanced Bioscience Resources, Alameda, CA). Written informed consent from the maternal
donor was obtained in all cases under regulations governing the clinic. All animal studies were
conducted following NIH guidelines for housing and care of laboratory animals. The project
was reviewed by the University’s Office of Human Research Ethics, which determined that this
submission does not constitute human subjects research as defined under federal regulations
[45 CFR 46.102 (d or f) and 21 CFR 56.102(c)(e)(l)].
Construction of humanized mice
We constructed humanized Balb/c rag2-γc (DKO) mice and Nod-rag1-γc (NRG) mice (The
Jackson Laboratory) in a similar manner as previously reported [36]. Briefly, human CD34+
cells were isolated from 16- to 20-week-old fetal liver tissues (Advanced Bioscience Resources,
Alameda, CA). Tissues were digested with liver digest medium (Invitrogen, Frederick, MD).
The suspension was filtered through a 70-μm cell strainer (BD Falcon, Lincoln Park, NJ) and
centrifuged at 150 × g for 5 minutes to isolate mononuclear cells by Ficoll. After selection with
the CD34+ magnetic-activated cell sorting (MACS) kit, CD34+ HPCs (0.5 × 106) were injected
into the liver of each 2- to 6-day-old DKO or NRG mice, which had been previously irradiated
at 300 rad. More than 95% of the humanized mice were stably reconstituted with human leu-
kocytes in the blood (60–90% at 12–14 weeks). Each cohort had similar levels of engraftment.
All mice were housed at the University of North Carolina at Chapel Hill.
HIV-1 virus stocks and infection of humanized mice
An R5-tropic strain of HIV-1, JR-CSF, was used for chronic HIV-1 infection. All viruses were
generated by transfection of 293 T cells (SIGMA-ALORICH, Cat#12022001-1VL) with
pDC-dependent HPC depletion in HIV-1 infection
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pYK-JRCSF (NIH AIDS reagents program, Cat# 2708). Humanized mice with stable human
leukocyte reconstitution were infected with JR-CSF at a dose of 10 ng p24/mouse, through
intravenous (i.v.) injection. Humanized mice infected with 293 T mock supernatant were used
in control groups (S2 Fig). Viral genomic RNA in plasma was extracted using the QIAamp
Viral RNA Mini Kit (QIAGEN, Cat# 52904) according to the manufacturer’s instruction.
HIV-1 replication (genome copies/ml plasma) was measured by real-time PCR (ABI Applied
Biosystem) or by p24-FACS detection of productively infected human T cells.
Depletion of human pDCs in humanized mice
A monoclonal antibody specific to blood dendritic cell antigen-2 (BDCA2), 15B, was used to
treat humanized mice through intra-peritoneal (i.p.) injection (4 mg/kg) as previously
reported [29]. Briefly, 15B was applied to mice at 7 weeks post-infection by injecting twice
every week for another 4 weeks.
Animal termination and tissue processing
For chronic JR-CSF infection, mice were terminated at 12 week post-infection. On termina-
tion, total leukocytes were isolated from mouse lymphoid organs as previously described
[29,34–36]. Lymphoid tissues, including peripheral blood (PB), peripheral lymph nodes
(pLN), mesenteric lymph nodes (mLN), spleen and BM were harvested for analysis. Red blood
cells were lysed with ACK buffer, and the remaining cells were stained and fixed with 1% (wt/
vol) formaldehyde before FACS analysis. The total cell number was quantified by using Guava
Easycytes with Guava Express software (Guava). Human BM cells were isolated by ficoll-hypa-
que density gradient centrifugation and collected for further analysis.
Antibodies and flow cytometry
Surface and intracellular fluorochrome-conjugated antibodies or reagents from Biolegend, BD
Bioscience, eBioscience and R&D Systems were used in this study. For humanized mice, live
human leukocytes (Y7-mCD45-hCD45+) were analyzed for HPC subsets or phenotypic expres-
sion by using the CyAn FACS instrument (Dako). Live/dead fixable violet dead cell dye (LD7)
was purchased from Molecular Probes (Eugene, OR). For intracellular p24 staining, freshly
isolated cells were collected for surface staining, followed by cell permeabilization using a
Cytofix/Cytoperm kit (BD Bioscience) and intracellular staining and washing. The data were
analyzed using Summit Software.
BrdU labeling in vivo
5-Bromo-2’-deoxyuridine (BrdU, Cat#: B5002, Sigma-Aldrich, St. Louis, MO) was first dis-
solved in water at a concentration of 10 mg/mL for stock in -20˚C. The BrdU stock was then
diluted in 200 μL PBS and injected i.p. at 100 mg/kg body weight. Four hours later, the mice
were terminated, and BM cells were collected. BrdU staining was performed according to
the manufacturer’s instructions. In brief, cells were first stained for surface markers and then
incubated with a working solution of the BrdU staining buffer for 15 minutes, followed by
incubation with DNase I (BIO-RAD, Cat#: 7326828) for 1 hour at 37˚C in the dark. Thereafter,
the cells were stained with the FITC-conjugated anti-BrdU antibody for 30 minutes at room
temperature in the dark and subsequently washed. The data were analyzed using Summit
Software.
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Colony-forming assays
The EasySep human CD34+ selection kit (Cat#:18056, StemCell Tech, Canada) was used to iso-
late CD34+ cells from frozen BM cells. The purity of CD34+ cells was greater than 90%. The
CD34+ cells were then counted and seeded in complete methylcellulose (Methocult H04034;
Stem Cell Technologies) at a concentration of 500 cells/mL and plated in 35-mm grid plates, 1
mL/plate, in triplicate per mouse according to the manufacturer’s instructions. Colonies were
counted 2 weeks later in a blinded fashion using a QImaging Micropublisher 3.3 CCD digital
camera and QCapture software version 3.0 (QImaging, Surrey, BC).
Cell purification by FACS sorting
BM cells were pooled by mouse groups for human CD45+ cells sorting. Cells were stained with
human CD45, mouse CD45 and 7-Aminoactinomycin D (7-AAD). For human CD34+ HSC
sorting, anti-lineage (anti-CD3, anti-CD14, anti-CD16, anti-CD19, anti-CD20 and anti-
CD56) and anti-CD34 antibodies were added to the antibody mix. Cell sorting was performed
by the UNC Flow Cytometry Core.
In vitro HPC maturation and expansion experiments
CD34+ cells were isolated from human fetal liver tissues. Then the cells were cultured in Stem-
Span SFEM medium (Stem Cell Technologies) with heparin (10 μg/ml, Sigma), recombinant
human SCF (20 ng/ml, R&D), thrombopoietin (40 ng/ml, Cell Sciences) and CHIR99021
(GSK3 inhibitor, 250 nM, STEMGENT) for 48 hours in the presence of IFN-α or IFN-β at the
dose of 20 IU/ml and 200 IU/ml, respectively. The cells were counted and collected for the
detection of CD38 expression on HPCs.
Agilent microarray assay
RNA purification was carried out using the RNeasy Plus Mini Kit (Cat# 74134, QIAGEN,
Venlo, Limburg, Netherlands) according to the manufacturer’s instructions. DNase (QIA-
GEN) treatment was added to the column to eliminate any potential DNA contamination dur-
ing RNA preparations. Total RNA was checked for quantity, purity and integrity by capillary
electrophoresis. RNA was amplified with Cy3- and Cy5-labeled CTP in separate reactions to
produce differentially labeled samples and reference cDNAs. Total RNA (200 ng to 400 ng)
was used as the starting material to prepare cDNA. Both samples were hybridized to the same
microarray (UNC Genomic and Bioinformatics Core) using SurePrint G3 Human Gene
Expression 8 ^ 60K Microarray Kit (Agilent). Agilent Feature Extraction v18 software was
used to analyze all images. Gene expression values were quantified by the log2 ratio of the red
channel intensity (mean) vs. green channel intensity (mean), followed by LOWESS normaliza-
tion to remove the intensity-dependent dye bias.
Statistical analysis
Data were analyzed using GraphPad Prism software version 5.0 (GraphPad software, San
Diego, CA). Data from different cohorts of mice were compared using a 2-tailed unpaired T
test. All results were considered significant for P values< 0.05.
Supporting information
S1 Table. The expression of HSC-associated genes in HIV-infected mice with or without
pDCs depletion.
(DOCX)
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S1 Fig. Gating strategy for CD34+ HPCs from BM in humanized mice. After gating on lym-
phocytes (FSC-SSC), singlets and live human CD45+ cells, the lineage-CD34+ cells that
remained were identified as total HPCs. Based on CD38 expression, HPCs were further
divided into CD38- early and CD38+ intermediate HPC subpopulations. The lineage markers
included CD3, CD14, CD16, CD19, CD20 and CD56.
(TIF)
S2 Fig. Establishment of persistent HIV-1 infection in humanized mice (n = 9).
(TIF)
S3 Fig. Representative pictures showing morphology of colonies differentiated from
CD34+ HPCs in BM of humanized mice. CFU-GM, colony-forming unit-granulocyte, mac-
rophage. CFU-E, colony-forming unit-erythroid. CFU-GEMM, colony-forming unit-granulo-
cyte, erythroid, macrophage, megakaryocyte.
(TIF)
S4 Fig. Dependence of recovery of CD34+CD38- early HPCs on pDC depletion status. (A)
Plasma HIV-1 load at the termination of humanized mice with HIV-1 infection with or with-
out pDC depletion. (B) Depletion of pDCs did not influence the CD38 expression and BrdU
expression on HPCs in the BM from humanized mice (each group, n = 3) in the absence of
HIV-1 infection. (C-G) Differences in CD34+CD38- early HPC proportion (C), CD34+CD38+
intermediate HPC proportion (D), BM pDC percentage (E), plasma IFN-α level (F) and
plasma HIV-1 load (G) between rescued (n = 7) and non-rescued (n = 6) groups in humanized
mice with HIV-1 infection after pDC depletion. Mice with less than the median percentage of
CD34+CD38- HPCs were defined as the non-rescued group (n = 6), while others were defined
as the rescued group (n = 7). (H) Correlation analysis between the percentage of CD34+CD38-
HPCs and the percentage of pDCs among CD45+ cells in BM of HIV-1 infected humanized
mice with pDC depletion (Spearman correlation test). r, correlation coefficient; P values are
shown.
(TIF)
S5 Fig. Distribution of significantly up-regulated or down-regulated gene numbers in BM
CD34+ HPC cells from HIV-1-infected mice with IgG and 15B relative to mock mice.
(TIF)
S6 Fig. Relative expression of ISGs in BM CD34+ HPC cells from HIV-1-infected mice
treated with IgG and 15B over mock mice. (A) Heat map showing the relative expression of
ISGs indicated by the color bars in huCD45+Lin-CD34+ cells from HIV-1-infected mice
treated with IgG and 15B relative to mock samples (green, suppressed genes; red, induced
genes. Fold change 2). (B) Table showing relative expression levels of ISGs in HIV-
1-infected mice treated with IgG and 15B relative to mock mice.
(TIF)
S7 Fig. Expression of HPC-associated genes in BM CD34+ HPC cells from HIV-infected
mice with or without pDC depletion. (A) Heat map showing relative expression of 88 genes
in the hematopoietic cell lineage pathway indicated by the color bars in huCD45+Lin-CD34+
cells from HIV-1-infected mice over mock samples (green, suppressed genes; red, induced
genes. Fold change 2). (B) Table showing numbers of significantly up-regulated or down-
regulated genes in the HPC pathway in HIV-1-infected mice treated with IgG and 15B relative
to mock mice. Δ change, D-value between HIV-1+IgG and HIV-1+15B. (C) Fold changes in
expression of 88 genes from hematopoietic cell lineage in HIV-1-infected mice with or without
pDC-dependent HPC depletion in HIV-1 infection
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pDC depletion in relation to mock mice.
(TIF)
S8 Fig. Depletion of pDCs slightly changes the dysregulated gene expression profile of
splenic CD45+ cells affected by HIV-1 infection. (A) Heat map showing the relative gene
expression indicated by the colored bars in huCD45+ cells from the spleen of HIV-1-infected
humanized mice over mock samples (green, suppressed genes; red, induced genes). (B)
Table showing the number of genes significantly up-regulated and down-regulated in splenic
CD45+ cells from HIV-1-infected humanized mice with or without pDC depletion. (C)
Table showing the KEGG pathway analysis of the top 8 most altered pathways in splenic
CD45+ cells from HIV-1-infected humanized mice relative to mock samples. (D) Heat map
showing the relative gene expression of the SLE pathway indicated by the colored bars in
splenic huCD45+ cells of HIV-1-infected humanized mice over mock samples (green, sup-
pressed genes; red, induced genes). (E) Table showing numbers of significantly up-regulated
or down-regulated genes in SLE pathway in HIV-1-infected mice with IgG and 15B relative to
mock mice. Δ change, D-value between HIV-1+IgG minus HIV-1+15B. (F) Fold changes of 88
genes from SLE pathway in HIV-1-infected mice with or without pDC depletion in relation to
mock mice.
(TIF)
S9 Fig. IFN-I slightly up-regulated CD38 expression on HPCs in vitro. (A and B) Represen-
tative dot plots (A) and pool data (n = 3, B) indicated CD38 expression on purified CD34+
fetal liver-derived HPCs in vitro of 24- and 48-hours in the presence of IFN-α and IFN-β at 20
IU/ml and 200 IU/ml doses. The numbers in (A) indicated that the CD38 percentages on
HPCs.  p< 0.05. (C) Pool data indicated the cell counts of CD34+ HPCs in vitro after 24- and
48-hour culture in the presence of IFN-I (n = 3).
(TIF)
S10 Fig. A model of HIV-1-induced hematopoietic suppression via pDC-dependent mech-
anisms. HIV-1 infection activates pDCs, possibly through type I IFNs, IL-6 and TNF-α,
suppresses self-renewal proliferation of early CD34+CD38- HPCs and dysregulates gene
expression profile in HPCs leading to their depletion and functional impairment. This effect
on early HSCs subsequently contributes to HIV-1-induced pathogenesis such as loss of all
human leukocyte cells (pancytopenia). Suppression of HIV-1 replication by① cART,②
depletion of pDC or③ blocking reagents against pDC-derived cytokines will restore HSC
number and function.
(TIF)
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